A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder.

Autor: Homma, Yukio1 homma-uro@umin.ac.jp, Yamaguchi, Osamu2
Zdroj: International Journal of Urology. May2009, Vol. 16 Issue 5, p499-506. 8p. 5 Charts.
Databáze: Academic Search Ultimate